Question 1

Does Erste Asset Management own INBX stock?

Accepted Answer

No. Erste Asset Management exited its INBX (Inhibrx Biosciences) position in Q4 2024. Its Q3 2024 13F listed 2,175 shares worth $33,756.

Question 2

How many shares of INBX does Erste Asset Management own?

Accepted Answer

None since Q4 2024, when Erste Asset Management exited the position. Its Q3 2024 13F listed 2,175 shares worth $33,756.

Question 3

What is Erste Asset Management's INBX position worth?

Accepted Answer

Erste Asset Management's INBX position was worth $33,756 in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is Erste Asset Management buying or selling INBX?

Accepted Answer

In Q4 2024, Erste Asset Management exited its entire INBX position.

Question 5

When did Erste Asset Management first buy INBX?

Accepted Answer

Erste Asset Management already held INBX in its Q2 2024 13F, the earliest on record, and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$15.14	0
2024-Q3	Unchanged	2,175	0.0%	$33,756	0.0%	$15.52	0